scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1029810297 |
P356 | DOI | 10.1023/A:1022367311529 |
P698 | PubMed publication ID | 12652173 |
P2093 | author name string | Panos E Vardas | |
George E Kochiadakis | |||
Nikolaos E Igoumenidis | |||
Hercules E Mavrakis | |||
Emmanuel G Manios | |||
Emmanuel M Kanoupakis | |||
P2860 | cites work | Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy | Q32033393 |
Evidence-based analysis of amiodarone efficacy and safety | Q33771489 | ||
Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent | Q33777249 | ||
High-density mapping of electrically induced atrial fibrillation in humans | Q34727687 | ||
Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors | Q35225966 | ||
Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias | Q35313411 | ||
Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study | Q35567061 | ||
Method and theory of monophasic action potential recording | Q37712936 | ||
Endocardial monophasic action potentials. Correlations with intracellular electrical activity | Q37973107 | ||
Basic concepts in cellular cardiac electrophysiology: Part II: Block of ion channels by antiarrhythmic drugs | Q40377415 | ||
Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia | Q40692991 | ||
Cellular electropharmacology of amiodarone | Q40888033 | ||
Intravenous amiodarone | Q41459856 | ||
Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy | Q42229679 | ||
Drug interactions with amiodarone | Q42241981 | ||
A model of the ventricular cardiac action potential. Depolarization, repolarization, and their interaction | Q45172101 | ||
Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. | Q45985183 | ||
Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone | Q46989385 | ||
Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values. | Q52375946 | ||
Electrophysiological mechanisms underlying rate-dependent changes of refractoriness in normal and segmentally depressed canine Purkinje fibers. The characteristics of post-repolarization refractoriness. | Q54432956 | ||
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines a | Q56987002 | ||
A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient | Q64763058 | ||
Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter | Q68142631 | ||
Amiodarone in the management of refractory atrial fibrillation | Q68186769 | ||
Amiodarone | Q68930408 | ||
Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium | Q69258719 | ||
Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects | Q69637324 | ||
Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite | Q69688204 | ||
Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia | Q70577599 | ||
Frequency-dependent electrophysiologic effects of amiodarone in humans | Q72885808 | ||
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators | Q73594702 | ||
P433 | issue | 1 | |
P921 | main subject | amiodarone | Q410061 |
atrial fibrillation | Q815819 | ||
cardioversion | Q1729126 | ||
P304 | page(s) | 19-26 | |
P577 | publication date | 2003-02-01 | |
P1433 | published in | Journal of Interventional Cardiac Electrophysiology | Q5271168 |
P1476 | title | Pharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: is it reasonable? | |
P478 | volume | 8 |
Q22306351 | ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | cites work | P2860 |
Search more.